The deployment of artesunate for severe malaria and the artemisinin combination therapies
(ACTs) for uncomplicated malaria has been a major advance in antimalarial therapeutics …

Malaria disproportionately affects children younger than 5 years. Falciparum malaria is
responsible for more than 200 000 child deaths per year in Africa and vivax malaria is well …

Malaria cases and deaths remain unacceptably high and are resurgent in several settings,
though recent developments inspire optimism. This includes the approval of the world's first …

The dynamics of CD4+ T cell memory development remain to be examined at genome
scale. In malaria-endemic regions, antimalarial chemoprevention protects long after its …

The populations of moderate or highly malaria endemic areas gradually acquire some
immunity to malaria as a result of repeated exposure to the infection. When this exposure is …

Malaria is a major global health problem. Despite decades of research, there is still no
effective vaccine to prevent disease in the majority of people living in malaria‐endemic …

Intermittent preventive treatment (IPT) with dihydroartemisinin-piperaquine (DP) is highly
protective against malaria in children, but is not standard in malaria-endemic countries …

Summary Background In many sub-Saharan African countries, it is recommended that
children with sickle cell anaemia receive malaria chemoprevention with monthly sulfadoxine …

Background Malaria in pregnancy has been associated with worse cognitive outcomes in
children, but its association with behavioral outcomes and the effectiveness of malaria …

Blood–brain barrier (BBB) injury is involved in the pathogenesis of sepsis‐associated
encephalopathy. In this study, we used dihydroartemisinin (DHA), a derivative of artemisinin …